PressCise raises SEK 4.8M in funding.

Sweden Investments 07 September 2017
Share on FacebookShare on Twitter

PressCise, a Herrljunga, Sweden-based company developing innovative medical products, raised SEK 4.8M ($610k) in outside funding. The money comes from Almi Invest (2M) and some other local undisclosed investors.

PressCise, led by CEO Anders Nilsson, develops novel compression products for a global market, within medical, sport and veterinary medicine, by using the research and cross-disciplinary collaboration between medicine, mathematics and textile technology. The money from funding will be used for launching commercially a first product, Lundatex.